Bioseal, Central Line Dressing Kit, containing ChloraPREP Applicator 3 mL, REF: CVC015/20, Steril...

FDA Device Recall #Z-1622-2021 — Class II — March 23, 2021

Recall Summary

Recall Number Z-1622-2021
Classification Class II — Moderate risk
Date Initiated March 23, 2021
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Bioseal Corporation
Location Placentia, CA
Product Type Devices
Quantity 1,560 units

Product Description

Bioseal, Central Line Dressing Kit, containing ChloraPREP Applicator 3 mL, REF: CVC015/20, Sterile EO, UDI: (01)00630094430157

Reason for Recall

Pre-op skin prep component ChloraPrep included within kits may allow the growth of Aspergillus penicillioides, which may penetrate the packaging resulting in a breach of the package integrity.

Distribution Pattern

US: IL and MO OUS: None

Lot / Code Information

Affected Lot Numbers: 400530 400528, 400536, 400537, 400514, 400522, 400514, 400514, 400522, 400514, 400569, 400569, 400565, 400569, 400565, 400556, 400556, 400556, 400540, 400562, 400537, 400530, 400537, 400530, 400537

Other Recalls from Bioseal Corporation

Recall # Classification Product Date
Z-1624-2021 Class II Bioseal, Central Line Dressing Kit, containing ... Mar 23, 2021
Z-1623-2021 Class II Bioseal, Chest Tube Insertion Tray, containing ... Mar 23, 2021
Z-2795-2020 Class II Bioseal Trachea Extender 1/pl 50pk/Cs, REF TRAX... Aug 15, 2019
Z-0085-2018 Class II Custom surgical kits labeled as follows: (a) S... Oct 18, 2017

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.